The treatment of tuberculous meningitis in children with A combination of isoniazid, rifampicin and streptomycin (a preliminary report). 1979

N N Rahajoe, and N Rahajoe, and I Boediman, and M Said, and S Lazuardi

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007538 Isoniazid Antibacterial agent used primarily as a tuberculostatic. It remains the treatment of choice for tuberculosis. Isonicotinic Acid Hydrazide,Ftivazide,Isonex,Isonicotinic Acid Vanillylidenehydrazide,Phthivazid,Phthivazide,Tubazide,Acid Vanillylidenehydrazide, Isonicotinic,Hydrazide, Isonicotinic Acid,Vanillylidenehydrazide, Isonicotinic Acid
D008297 Male Males
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012293 Rifampin A semisynthetic antibiotic produced from Streptomyces mediterranei. It has a broad antibacterial spectrum, including activity against several forms of Mycobacterium. In susceptible organisms it inhibits DNA-dependent RNA polymerase activity by forming a stable complex with the enzyme. It thus suppresses the initiation of RNA synthesis. Rifampin is bactericidal, and acts on both intracellular and extracellular organisms. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1160) Rifampicin,Benemycin,Rifadin,Rimactan,Rimactane,Tubocin
D013307 Streptomycin An antibiotic produced by the soil actinomycete Streptomyces griseus. It acts by inhibiting the initiation and elongation processes during protein synthesis. Estreptomicina CEPA,Estreptomicina Clariana,Estreptomicina Normon,Strepto-Fatol,Strepto-Hefa,Streptomycin GrĂ¼nenthal,Streptomycin Sulfate,Streptomycin Sulfate (2:3) Salt,Streptomycin Sulphate,Streptomycine Panpharma,Strepto Fatol,Strepto Hefa

Related Publications

N N Rahajoe, and N Rahajoe, and I Boediman, and M Said, and S Lazuardi
January 1989, Scandinavian journal of infectious diseases,
N N Rahajoe, and N Rahajoe, and I Boediman, and M Said, and S Lazuardi
March 1954, Il Policlinico. Sezione pratica,
N N Rahajoe, and N Rahajoe, and I Boediman, and M Said, and S Lazuardi
October 1953, Lancet (London, England),
N N Rahajoe, and N Rahajoe, and I Boediman, and M Said, and S Lazuardi
June 1948, America clinica,
N N Rahajoe, and N Rahajoe, and I Boediman, and M Said, and S Lazuardi
May 1989, The Journal of pediatrics,
N N Rahajoe, and N Rahajoe, and I Boediman, and M Said, and S Lazuardi
February 1948, Journal of the American Medical Association,
N N Rahajoe, and N Rahajoe, and I Boediman, and M Said, and S Lazuardi
January 1985, Revista latinoamericana de microbiologia,
N N Rahajoe, and N Rahajoe, and I Boediman, and M Said, and S Lazuardi
January 1956, Antibiotic medicine & clinical therapy (New York, NY),
N N Rahajoe, and N Rahajoe, and I Boediman, and M Said, and S Lazuardi
June 1950, The New Zealand medical journal,
N N Rahajoe, and N Rahajoe, and I Boediman, and M Said, and S Lazuardi
June 1954, Lancet (London, England),
Copied contents to your clipboard!